Relationships between lipid profiles and metabolic syndrome, insulin resistance and serum high molecular adiponectin in Japanese community-dwelling adults

Lipids in Health and Disease

Volumn 10, Issue , 2011, Pages

  Kawamoto, Ryuichi ^a,b   Tabara, Yasuharu ^a   Kohara, Katsuhiko ^a   Miki, Tetsuro ^a   Kusunoki, Tomo ^a,b   Takayama, Shuzo ^a   Abe, Masanori ^a   Katoh, Tateaki ^b   Ohtsuka, Nobuyuki ^b  

^a EHIME UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b Seiyo Municipal Nomura Hospital   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; ALCOHOL; CHOLESTEROL; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; BIOLOGICAL MARKER; LIPID;

ADULT; AGED; ALCOHOL CONSUMPTION; ARTICLE; BODY MASS; CARDIOVASCULAR DISEASE; CHOLESTEROL BLOOD LEVEL; DIABETES MELLITUS; DIET RESTRICTION; DISEASE ASSOCIATION; DISEASE MARKER; DYSLIPIDEMIA; FEMALE; GLUCOSE BLOOD LEVEL; HOMEOSTASIS; HUMAN; HYPERTENSION; INSULIN RESISTANCE; JAPANESE; LIPID ANALYSIS; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; ASIAN; BLOOD; DEMOGRAPHY; JAPAN; MIDDLE AGED; MOLECULAR WEIGHT; PREVALENCE; RECEIVER OPERATING CHARACTERISTIC; RISK FACTOR; STATISTICAL MODEL;

ADIPONECTIN; ADULT; AGED; AGED, 80 AND OVER; ASIAN CONTINENTAL ANCESTRY GROUP; BIOLOGICAL MARKERS; FEMALE; HUMANS; INSULIN RESISTANCE; JAPAN; LINEAR MODELS; LIPIDS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; MOLECULAR WEIGHT; PREVALENCE; RESIDENCE CHARACTERISTICS; RISK FACTORS; ROC CURVE; YOUNG ADULT;

EID: 79955963344     PISSN: None     EISSN: 1476511X     Source Type: Journal    
DOI: 10.1186/1476-511X-10-79     Document Type: Article

References (34)

1. Role of insulin resistance in human disease. GM Reaven, Diabetes 1988 37 12 1595 1607 10.2337/diabetes.37.12.1595 3056758 (Pubitemid 19004941)
2. Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. RA DeFronzo E Ferrannini, Diabetes Care 1991 14 3 173 194 10.2337/diacare.14.3. 173 2044434
3. Metabolic syndrome and cardiac disease in Japanese men: applicability of the concept of metabolic syndrome defined by the National Cholesterol Education Program-Adult Treatment Panel III to Japanese men-the Tanno and Sobetsu Study. H Takeuchi S Saitoh S Takagi H Ohnishi J Ohhata T Isobe K Shimamoto, Hypertens Res 2005 28 3 203 208 10.1291/hypres.28.203 16097362 (Pubitemid 40812603)
4. Prevalence of the metabolic syndrome using the modified ATP III definitions for workers in Japan, Korea and Mongolia. K Shiwaku A Nogi K Kitajima E Anuurad B Enkhmaa M Yamasaki JM Kim IS Kim SK Lee T Oyunsuren Y Yamane, J Occup Health 2005 47 2 126 135 10.1539/joh.47.126 15824477 (Pubitemid 40570159)
5. Metabolic syndrome and risk of cardiovascular disease: a meta-analysis. A Galassi K Reynolds J He, Am J Med 2006 119 10 812 819 10.1016/j.amjmed.2006.02. 031 17000207 (Pubitemid 44415613)
6. Risks for all-cause mortality, cardiovascular disease, and diabetes associated with the metabolic syndrome: a summary of the evidence. ES Ford, Diabetes Care 2005 28 7 1769 1778 10.2337/diacare.28.7.1769 15983333 (Pubitemid 40923091)
7. Adiponectin in insulin resistance: lessons from translational research. F Ziemke CS Mantzoros, Am J Clin Nutr 2010 91 1 258S 261S 10.3945/ajcn.2009. 28449C 19906806
8. High-molecular-weight adiponectin is a predictor of progression to metabolic syndrome: a population-base 6-year follow-up study in Japanese men. Y Seino H Hirose I Saito H Itoh, Metabolism 2009 58 3 355 360 10.1016/j.metabol. 2008.10.008 19217451
9. Plasma adiponectin levels and risk of myocardial infarction in men. T Pischon CJ Girman GS Hotamisligil N Rifai FB Hu EB Rimm, JAMA 2004 291 14 1730 1737 10.1001/jama.291.14.1730 15082700 (Pubitemid 38489895)
10. Adiponectin multimeric complexes and the metabolic syndrome trait cluster. C Lara-Castro N Luo P Wallace RL Klein WT Garvey, Diabetes 2006 55 1 249 259 10.2337/diabetes.55.01.06.db05-1105 16380500 (Pubitemid 43343322)
11. Summary of the second report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II). Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults, JAMA 1993 269 23 3015 3023 8501844
12. Insulin resistance, the insulin resistance syndrome, and cardiovascular disease. GM Reaven, Panminerva Med 2005 47 4 201 210 16489319 (Pubitemid 43471964)
13. Associations between lipid measures and metabolic syndrome, insulin resistance and adiponectin. - Usefulness of lipid ratios in Korean men and women -. H Kimm SW Lee HS Lee KW Shim CY Cho JE Yun SH Jee, Circ J 2010 74 5 931 937 10.1253/circj.CJ-09-0571 20215701
14. Is there a simple way to identify insulin-resistant individuals at increased risk of cardiovascular disease? T McLaughlin G Reaven F Abbasi C Lamendola M Saad D Waters J Simon RM Krauss, Am J Cardiol 2005 96 3 399 404 10.1016/j.amjcard.2005.03.085 16054467 (Pubitemid 41058868)
15. Use of metabolic markers to identify overweight individuals who are insulin resistant. T McLaughlin F Abbasi K Cheal J Chu C Lamendola G Reaven, Ann Intern Med 2003 139 10 802 809 14623617
16. Evidence for an independent relationship between insulin resistance and fasting plasma HDL-cholesterol, triglyceride and insulin concentrations. A Laws GM Reaven, J Intern Med 1992 231 1 25 30 10.1111/j.1365-2796.1992.tb00494.x 1732395
17. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. WT Friedewald RI Levy DS Fredrickson, Clin Chem 1972 18 6 499 502 4337382
18. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. DR Matthews JP Hosker AS Rudenski BA Naylor DF Treacher RC Turner, Diabetologia 1985 28 7 412 419 10.1007/BF00280883 3899825 (Pubitemid 15018832)
19. Definition and criteria for the diagnosis of metabolic syndrome. Examination committee of criteria for diagnosis of metabolic syndrome in Japan, J Jpn Soc Int Med 2005 94 4 794 809
20. New criteria for 'obesity disease' in Japan. The examination Committee of Criteria for "Obesity Disease" in Japan. Japan Society for Study of Obesity, Circ J 2002 66 11 987 992 10.1253/circj.66.987 12419927
21. Relationship between several surrogate estimates of insulin resistance and quantification of insulin-mediated glucose disposal in 490 healthy nondiabetic volunteers. H Yeni-Komshian M Carantoni F Abbasi GM Reaven, Diabetes Care 2000 23 2 171 175 10.2337/diacare.23.2.171 10868826 (Pubitemid 30071019)
22. Insulin Resistance, the Metabolic Syndrome, and Incident Cardiovascular Events in the Framingham Offspring Study. MK Rutter JB Meigs LM Sullivan Sr D'Agostino RB PW Wilson, Diabetes 2005 54 11 3252 3257 10.2337/diabetes.54.11. 3252 16249452 (Pubitemid 43334382)
23. How good a marker is insulin level for insulin resistance? M Laakso, Am J Epidemiol 1993 137 9 959 965 8317453 (Pubitemid 23191063)
24. Prevalence of insulin resistance in metabolic disorders: the Bruneck Study. E Bonora S Kiechl J Willeit F Oberhollenzer G Egger G Targher M Alberiche RC Bonadonna M Muggeo, Diabetes 1998 47 10 1643 1649 10.2337/diabetes.47.10. 1643 9753305 (Pubitemid 28445355)
25. Ageing and blood pressure modulate the relationship between metabolic syndrome and aortic stiffness in never-treated essential hypertensive patients. A comparative study. R El Feghali J Topouchian B Pannier R Asmar, Diabetes Metab 2007 33 3 183 188 10.1016/j.diabet.2006.11.011 17336118 (Pubitemid 46856250)
26. Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. C Weyer T Funahashi S Tanaka K Hotta Y Matsuzawa RE Pratley PA Tataranni, J Clin Endocrinol Metab 2001 86 5 1930 1935 10.1210/jc.86.5.1930 11344187 (Pubitemid 32472900)
27. Decreased plasma adiponectin concentrations in women with dyslipidemia. M Matsubara S Maruoka S Katayose, J Clin Endocrinol Metab 2002 87 6 2764 2769 10.1210/jc.87.6.2764 12050247 (Pubitemid 34655342)
28. Effects of acute hyperinsulinemia on VLDL triglyceride and VLDL apoB production in normal weight and obese individuals. GF Lewis KD Uffelman LW Szeto G Steiner, Diabetes 1993 42 6 833 842 10.2337/diabetes.42.6.833 8495807 (Pubitemid 23151575)
29. Should triglycerides and the triglycerides to high-density lipoprotein cholesterol ratio be used as surrogates for insulin resistance? SJ Kim-Dorner PA Deuster SA Zeno AT Remaley M Poth, Metabolism 2010 59 2 299 304 10.1016/j.metabol.2009.07.027 19796777
30. The prediction of insulin resistance with serum triglyceride and high-density lipoprotein cholesterol levels in an East African population. P Bovet D Faeh A Gabriel L Tappy, Arch Intern Med 2006 166 11 1236 1237 16772257 (Pubitemid 43877642)
31. Fasting triglyceride and the triglyceride-HDL cholesterol ratio are not markers of insulin resistance in African Americans. AE Sumner KB Finley DJ Genovese MH Criqui RC Boston, Arch Intern Med 2005 165 12 1395 1400 10.1001/archinte.165.12.1395 15983289 (Pubitemid 40973422)
32. Increased fasting triglyceride levels are associated with hepatic insulin resistance in Caucasian but not African-American adolescents. RP Hoffman, Diabetes Care 2006 29 6 1402 1404 10.2337/dc06-2460 16732033 (Pubitemid 44125947)
33. Associations between lipid measures and metabolic syndrome, insulin resistance and adiponectin. - Usefulness of lipid ratios in Korean men and women -. H Kimm SW Lee HS Lee KW Shim CY Cho JE Yun SH Jee, Circ J 2010 74 5 931 937 10.1253/circj.CJ-09-0571 20215701
34. Carotid atherosclerosis in normal-weight metabolic syndrome. R Kawamoto N Ohtsuka D Ninomiya S Nakamura, Intern Med 2007 46 21 1771 1777 10.2169/internalmedicine.46.0261 17978533 (Pubitemid 350131028)